Study of a new automated insulin system for diabetes
Part of Hormones & metabolism clinical trials.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 2 years or older
- You must have type 1 or type 2 diabetes for at least 6 months
- You must already use the MiniMed 780G pump with Simplera Sync sensor for at least 3 months
- Your HbA1c must be less than 11%
- You must take between 6 and 250 units of insulin daily
- You must be willing to follow the study schedule and training
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new experimental automated insulin delivery system (a type of 'artificial pancreas') to see if it is safe and works better than current systems. It may help people whose blood sugar is not well controlled with their current pump or system.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.